|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/18 | |
| A61K 39/395 | |||
| A61P 25/28 |
| (11) | Patento numeris | 2593475 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11807457.4 |
| Europos patento paraiškos padavimo data | 2011-07-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-03-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2011/043866 |
| Data | 2011-07-13 |
| (87) | Numeris | WO 2012/009442 |
| Data | 2012-01-19 |
| (30) | Numeris | Data | Šalis |
| 364210 P | 2010-07-14 | US |
| (72) |
GASPAR, Renee C., US
SHUGHRUE, Paul J., US
WANG, Fubao, US
WANG, Weirong, US
ZHANG, Ningyan, US
ZHAO, Wei-Qin, US
McCAMPBELL, Alexander, US
XU, Min, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | ANTI-ADDL MONOCLONAL ANTIBODY AND USES THEREOF |
| ANTI-ADDL MONOCLONAL ANTIBODY AND USES THEREOF |